Patient clinical outcome dichotomized into good (mRS score, ≤2) and poor clinical outcome (mRS score, >2) at 90 days
| Parameters | mRS Score ≤2 (n = 38) | mRS Score >2 (n = 47) | P Value |
|---|---|---|---|
| Age (yr), mean ± SD | 65 (±15.7) | 74 (±12.7) | .0088 |
| NCCT ASPECTS, median (IQR) | 9 (7–9) | 6 (4–7) | <.0001 |
| CBS, median (IQR) | 7.5 (6–9) | 6 (4–7) | .0005 |
| CS, median (IQR) | 2.5 (2–3) | 2 (1–2.5) | .0015 |
| Baseline NIHSS score, median (IQR) | 11 (6–16) | 19 (15–23) | <.0001 |
| rtPA, % (No.) | 76.3 (29) | 70.0 (31) | .3447 |
| rtPA dose (mg), mean ± SD | 62.2 ± 14.0 | 59.2 ± 18.9 | .9083 |
| Time to scanning (min), median (IQR) | 89 (65–120) | 120 (80–150) | .0267 |
| Recanalization, % (No.) | 57.9 (22) | 31.9 (15) | .0219 |
| Final infarct size (cm3), mean ± SD | 53 ± 72 | 172 ± 143 | <.0001 |
| Baseline CBF (cm3), mean ± SD | 85 ± 41 | 110 ± 56 | .0001 |
| Baseline CBV (cm3), mean ± SD | 22 ± 16 | 56 ± 45 | .0001 |
| Baseline MTT (cm3), mean ± SD | 109 ± 84 | 84 ± 42 | .0344 |
Note:—NCCT indicates noncontrast CT; IQR, interquartilerange; rtPA, recombinant tissue plasminogen activator.